LANSING, Mich., Nov. 13, 2008 (GLOBE NEWSWIRE) -- In August, Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) was pleased to announce that the award winning micro-biologist Dr. Fanghai Wang joined the scientific team to develop new high performance polymers using spider silk gene sequences. Today the Company is pleases to confirm that Dr. Wang has successfully completed a two week consultation in Japan regarding the development of silk polymers and genetic engineering techniques for modifying natural silk polymers.
"This consultation with the Japanese laboratory for the purpose of introducing new technologies for our research and product development was one of the Company's goals for 2008," said the Company's CEO Kim Thompson. "The new techniques that Dr. Wang has brought back are expected to significantly boost the pace of our research and development program within the University of Notre Dame. Dr. Wang has exceeded our expectations. This reinforces management's view that we are on track for the development of new high strength polymers."
"Dr. Wang's overseas consultation has engendered new excitement in the laboratory as we begin employing his methods," said Dr. Malcolm Fraser. "We are already gearing up to accelerate our work with these technologies." Dr. Wang was the second major scientist to join Kraig's research team within the last several months. The Company anticipates that it will be able to announce the hiring of additional high level scientists within the University research laboratory in the coming weeks.
Dr. Wang received his Ph.D. in 1996 from the Chinese Academy of Sciences in Beijing, China. His extensive research background includes work in research laboratories in Japan, China and the Czech Republic. He is the author or coauthor of more than a dozen scientific articles relating biology and bio-chemistry, and is the recipient of a Chinese Academy of Sciences Award.
Kraig is working to develop and commercialize high performance polymers using spider silk gene sequences. The company hopes to tap into the $92 billion market for high performance and technical fibers. In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research within the university.
For more information on Kraig Biocraft Laboratories, and to hear an audio interview with Kraig's CEO, please visit the Company's web site: www.KraigLabs.com
The Kraig Biocraft Laboratories, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4817
Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "hopes," "develops", "researching," "research," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.